Issues in Designing and Implementing a Spanish-Language Multi-Site Clinical Trial
Authors:
Lourdes Suarez-Morales a;
Julie Matthews b;
Steve Martino c;
Samuel A. Ball c;
Carmen Rosa d;
Christine Farentinos e;
Jos
Szapocznik a;
Kathleen M. Carroll c
Szapocznik a;
Kathleen M. Carroll c
| Affiliations: | a Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, Florida |
| b Advanced Behavioral Health, Middletown, Connecticut | |
| c Department of Psychiatry, Connecticut VA Healthcare Center, Yale University, West Haven, Connecticut | |
| d Center for the Clinical Trials Network, National Institute on Drug Abuse, Bethesda, Maryland | |
| e ChangePoint, Inc., Portland, Oregon |
DOI:
10.1080/10550490701375707
Publication Frequency:
6 issues per year
Subject:
Addiction & Treatment;
Formats available:
HTML
(English)
:
PDF
(English)
View Article:
View Article (PDF)
View Article (HTML)
Abstract
To address at least in part health disparities in Hispanic populations, the NIDA Clinical Trials Network implemented the first multi-site randomized clinical trial of substance abuse treatment conducted entirely in Spanish. This trial was intended to evaluate the effectiveness of Motivational Enhancement Therapy in a diverse population of Hispanics. In the conduct of this trial, several barriers to the successful implementation of a Spanish-language multi-site trial had to be addressed, including the appropriate translation of assessment instruments, shortage of appropriately trained Spanish-speaking clinical staff, and barriers to recruitment and retention of this population. To encourage similar research, strategies are described that were developed by the study team to meet these challenges.
|
| view references (37) |


Download Citation
CiteULike
Del.icio.us
BibSonomy
Connotea